Skubana LLC – Trademark Portfolio
Entity Type: 16
Skubana LLC holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include DIRECT TO EVERYWHERE. The owner is based in New York, NY.
379 West Broadway
New York, NY 10012
Showing of trademarks Trademarks
Trademark Classifications
Skubana LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Skubana LLC have?
Skubana LLC has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 5 cancelled.
What trademark classes does Skubana LLC file in?
Skubana LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Skubana LLC's most well-known trademarks?
Skubana LLC's registered trademark portfolio includes well-known marks such as DIRECT TO EVERYWHERE. These are among 1 currently registered trademark in the portfolio.
What is Skubana LLC's trademark registration success rate?
Skubana LLC has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.